Chen, Jian-Xin
Huang, Wen-Ting
Zhang, Qing-Yun
Deng, Cheng-En
Wei, Jue-ling
Xie, Yuan-Liang
Lin, Rui
Feng, Guan-Zheng
Yang, Guang-Lin
Long, Jun
Lu, Hao-Yuan
Mo, Zeng-nan
Funding for this research was provided by:
Development, Promotion and Application of Feasible Medical Health Technologies of Guangxi (S2019048)
Guangxi Natural Science Fundation (2021GXNSFAA196071)
Guangxi Key Research and Development Program (2021AB13014)
Major Project of Guangxi Innovation Driven (AA18118016)
Guangxi key Laboratory for Genomic and Personalized Medicine (16-380-54, 17-259-45, 19-050-22, 19-185-33, 20-065-33)
Article History
Received: 18 March 2023
Accepted: 13 October 2023
First Online: 23 October 2023
Declarations
:
: The authors declare no competing interests.
: Written informed consent was obtained from all the patients. All experimental protocols were in accordance with the guidelines and regulations and approved by the Ethics and Human Subjects Committee of Guangxi Medical University Cancer Hospital(Ethics Number:2021-KY-NSFC-006).
: Not applicable.